17h
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
It has been another frustrating season on the injury front for Luke Shaw, who has been restricted to just 98 minutes of first-team football at Manchester United ...
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results